Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › a Biogen blames lower-than-expected Tecfidera sales partly on safety concerns

 

a Biogen blames lower-than-expected Tecfidera sales partly on safety concerns

2015-04-24 22:54:30| Biotech - Topix.net

Biogen's Tecfidera was the biggest locally-developed drug to be approved in the U.S. in 2013. It's expected to make more than $4 billion in revenue in 2018.

Tags: sales safety concerns partly

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

05.11 Registration Now Open for RadTech 2025 05.11 Atlantic Tropical Weather Outlook 05.11 Eastern North Pacific Tropical Weather Outlook 05.11 Tropical Storm Rafael Graphics 05.11 Tropical Storm Rafael Public Advisory Number 7A 05.11 Summary for Tropical Storm Rafael (AT3/AL182024) 05.11 Vodafone-Three merger could get green light, watchdog says 05.11 Altice USA residential video RGUs down 77,000 in 3Q 2024 More »